Latest filing published 10 May 2019 for CytomX Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -11.3%Entry US$74.69 · Close at T+365 US$66.23
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Frederick W. Gluck: trading record in brief
Frederick W. Gluck discloses dealings in 3 companies, chiefly Amgen Inc, CytomX Therapeutics, Inc. and HCA Healthcare, Inc. Between 17 February 2006 and 8 April 2019, the trades on record add up to 40 filings.
On the open market, the record shows 3 purchases worth €450k and 19 sales worth €2.0M. On balance, insiders were net sellers of €1.5M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 7 share grants and 5 option exercises.
Half of the purchases are above €105k and half below.
On 10 May 2019 came the latest disclosure, a transaction in CytomX Therapeutics, Inc. The clock since the last published purchase (16 October 2015) now reads 4,042 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Frederick W. Gluck
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,900 shares0Common StockSEC:0001567619-19-010365:0
- 3,900 shares0Common StockSEC:0001567619-19-008682:0
- 3,900 shares0Common StockSEC:0001567619-19-008682:1
- 5,000 shares@ US$31.939.4% of flowCommon StockSEC:0001140361-18-015300:0
- 16,181 shares@ US$30.0028.9% of flowCommon StockSEC:0001140361-18-012114:0
- 3,819 shares@ US$30.006.8% of flowCommon StockSEC:0001140361-18-011514:0
- 10,000 shares@ US$25.0115.1% of flowCommon StockSEC:0001140361-18-001261:0
- 5,000 shares@ US$22.296.8% of flowCommon StockSEC:0001140361-17-047635:0
- 10,000 shares@ US$24.2715.1% of flowCommon StockSEC:0001140361-17-037760:0
- 5,000 shares@ US$17.305.4% of flowCommon StockSEC:0001140361-17-036614:0
- 5,000 shares@ US$14.614.8% of flowCommon StockSEC:0001140361-17-026278:0
- 31,767 shares@ US$1.13392.4% of flowCommon StockSEC:0001140361-16-075795:0
- 16,612 shares@ US$0.9451.0% of flowCommon StockSEC:0001140361-16-075795:1
- 27,606 shares@ US$1.44892.6% of flowCommon StockSEC:0001140361-16-075795:2
- 17,139 shares@ US$1.57491.8% of flowCommon StockSEC:0001140361-16-075795:3
- 331,643 shares0Common StockSEC:0000905148-16-001685:0
- 17,111 shares0Common StockSEC:0000905148-16-001685:1
- 10,000 shares@ US$12.00Common StockSEC:0001140361-15-037810:0Canonical exit: 12 Jan 2016 (T+90)
- 5,000 shares@ US$12.00Common StockSEC:0001140361-15-037810:1Canonical exit: 12 Jan 2016 (T+90)
- 1,828 shares0Common StockSEC:0001127602-11-013854:0
- 800 shares@ US$52.36Common StockSEC:0001127602-10-022847:0
- 800 shares@ US$51.76Common StockSEC:0001127602-10-022059:0
- 1,711 shares0Common StockSEC:0001127602-10-012355:0
- 1,982 shares0Common StockSEC:0001127602-09-010049:0
- 16,000 shares@ US$28.97Common StockSEC:0001127602-09-001733:0
25 of 40 declarations
